isabelobrien, Author at European Medical Journal - Page 4 of 29

DeepHealth’s Naiara Martínez Cabrera on AI's role in radiology

In this episode, uncover how AI is shaking up the radiology space with Naiara Martínez Cabrera, Vice President, Global Marketing, DeepHealth.

AstraZeneca buys EsoBiotec in $1bn cell therapy deal

AstraZeneca has announced a $1bn agreement to acquire EsoBiotec, a Belgian biotech firm pioneering in vivo cell therapies.

Tackling bias, driving change: A roundtable for International Women’s Day

How can the pharmaceutical industry ‘Accelerate Action’ on gender parity this International Women’s Day? Find out now.

Cartoon brain on green background

Phase 2 trial begins for psychedelic-based depression treatment

A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.

The word spotlight on a blue background

Spotlight: February 2025

From a historic vaccine approval to a $50bn investment reshaping US drug manufacturing, February brought major pharma news to the fore.

UK's NHS must boost medicine spending, ABPI warns

The UK must increase investment in innovative medicines and vaccines if it is to deliver on the NHS 10-Year Plan and drive economic growth.

Eli Lilly plans record $50bn US manufacturing investment

The company’s investment will expand its US manufacturing footprint and is the largest investment of its kind in history.

Handshake on a green background

AstraZeneca pays $160m for FibroGen's China subsidary

FibroGen, Inc. has announced the sale of its Chinese subsidiary to AstraZeneca, including the rights to roxadustat in China.

FDA fast-tracks Boehringer's NSCLC drug review

The FDA has granted priority review to zongertinib for non-small cell lung cancer (NSCLC).

FDA approves first at-home coeliac genetic test

A new at-home genetic test that assesses the risk of developing coeliac disease has received approval from US regulators.